JB Chemicals & Pharmaceuticals has informed that the Company’s API manufacturing facility- D9 located at Plot No. 5, GIDC, Panoli, Gujarat was inspected by the USFDA. The inspection was conducted from March 10, 2025 to March 13, 2025. At the end of the inspection, the facility received ‘No Observations’ and thus NO Form 483 was issued. The Company remains committed to producing quality products, embedding a quality culture across the organization and continuously investing in systems, processes & training of its employees so that it can maintain the highest standards of quality and compliance for all its markets.
The above information is a part of company’s filings submitted to BSE.
